General Information of Drug Transporter (DT)
DT ID DTD0428 Transporter Info
Gene Name SLC5A8
Transporter Name Sodium-coupled monocarboxylate transporter 1
Gene ID
160728
UniProt ID
Q8N695
Post-Translational Modification of This DT
Overview of SLC5A8 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A8 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

485

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC5A8 Asparagine 485 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

25

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 25 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

42

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 42 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A8 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

202

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 202 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A8 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A8 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

576

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 576 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC5A8 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

599

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 599 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC5A8 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

602

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Serine 602 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

3

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Threonine 3 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Threonine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

41

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Threonine 41 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A8 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

188

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Threonine 188 has the potential to affect its expression or activity.

  Tyrosine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Tyrosine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

31

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Tyrosine 31 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC5A8 [2]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

32

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Tyrosine 32 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC5A8 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

79

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Tyrosine 79 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC5A8 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

222

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC5A8 Tyrosine 222 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SC5A8_HUMAN)
2 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
3 Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6 Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer. Anal Chem. 2010 Feb 1;82(3):824-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.